Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alex azar
life sciences
medicare
national
3
×
national blog main
national top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
donald trump
drug pricing
fda
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alirocumab
alliance for aging research
american patients first
amgen
biogen
biosimilars
biotechnology innovation organization
What
drug
3
×
trump
3
×
administration
blueprint
plan
prescription
prices
afternoon
angry
announced
anti
anticipated
awaited
benefited
biopharma
cheaper
cost
cut
despite
details
drugs
fear
foreign
house
industry
long
losing
lower
lowering
meant
medicare
observers
ones
pharma
plans
pledges
president
presidential
price
rhetoric
Language
Current search:
drug
×
national
×
trump
×
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details